Thermo Fisher Scientific partners with HEALTH BioMed to support molecular diagnostics development in China
Thermo Fisher Scientific and HEALTH BioMed (HBM) have announced a collaboration to support HBM’s development of molecular diagnostic (MDx) kits for infectious disease and pharmacogenomics screening to serve the China market. Under the terms of a strategic agreement, HBM will submit all kits it develops on the Applied Biosystems 3500Dx Capillary Electrophoresis (CE) platform through […]
